Effect of Co-Treatment of Olanzapine with SEP-363856 in Mice Models of Schizophrenia
Sign Up to like & getrecommendations! Published in 2022 at "Molecules"
DOI: 10.3390/molecules27082550
Abstract: Olanzapine is a commonly used drug in the treatment of schizophrenia, but its clinical application has been restricted by metabolic-related side effects. In order to mitigate the weight gain side effects caused by olanzapine, other… read more here.
Keywords: treatment olanzapine; treatment; sep 363856; olanzapine sep ... See more keywords
The Potential Antidepressant Action of Duloxetine Co-Administered with the TAAR1 Receptor Agonist SEP-363856 in Mice
Sign Up to like & getrecommendations! Published in 2022 at "Molecules"
DOI: 10.3390/molecules27092755
Abstract: Here, we explored the possible interaction between duloxetine and SEP-363856 (SEP-856) in depression-related reactions. The results showed that oral administration of duloxetine showed powerful antidepressant-like effects in both the forced swimming test (FST) and the… read more here.
Keywords: antidepressant like; sep 363856; duloxetine; duloxetine sep ... See more keywords